On 2025-08-11, Acurx Pharmaceuticals, Inc. (ACXP) announced earnings per share of $-1.89 for the fiscal quarter ending 2025-06-30, beating the average analyst estimate of $-2.00.
The next expected annoucement date for quarterly earnings is 2025-11-11, with an average estimated earnings per share of $-1.61 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-11 | 2025-06-30 | $-2.00 | $-1.89 |
| 2025-05-12 | 2025-03-31 | -- | $-2.20 |
| 2025-03-17 | 2024-12-31 | -- | $-3.20 |
| 2024-11-12 | 2024-09-30 | $-4.60 | $-3.40 |
| 2024-08-09 | 2024-06-30 | $-5.60 | $-5.20 |
| 2024-05-14 | 2024-03-31 | $-4.80 | $-5.60 |
| 2024-03-15 | 2023-12-31 | $-5.20 | $-7.60 |
| 2023-11-13 | 2023-09-30 | $-5.60 | $-4.80 |
| 2023-08-14 | 2023-06-30 | $-5.80 | $-5.60 |
| 2023-05-12 | 2023-03-31 | $-6.80 | $-5.00 |
| 2023-03-16 | 2022-12-31 | $-5.00 | $-5.60 |
| 2022-11-14 | 2022-09-30 | -- | $-6.40 |
| 2022-08-15 | 2022-06-30 | -- | $-5.20 |
| 2022-05-11 | 2022-03-31 | -- | $-5.20 |
| 2022-03-17 | 2021-12-31 | -- | $-4.60 |
| 2021-11-12 | 2021-09-30 | -- | $-9.20 |
| 2021-08-16 | 2021-06-30 | -- | $-11.40 |